BioSculpture Technology, Inc.
Commercial stage medical device manufacturer developing a patented, prototyped minimally invasive treatment of obesity, metabolic syndrome and type 2 diabetes.
BioSculpture Technology, Inc., is a medical device company manufacturing advanced liposuction instruments under worldwide patent portfolio (17US, 1 EPO) and trademark protection (8 US TM). Airbrush® II is already approved by the F.D.A. under a 510(k). It's patented technology have already generated over $500k of royalties and a $1.6M PO.